PrEP in Prisons: HIV prevention in incarcerated populations

Pages199-206
DOIhttps://doi.org/10.1108/IJPH-09-2019-0053
Published date26 November 2019
Date26 November 2019
AuthorJordan Parsons,Chelsea Cox
Subject MatterHealth & social care,Criminology & forensic psychology,Prisoner health,Sociology,Sociology of crime & law,Public policy & environmental management,Policing,Criminal justice
PrEP in Prisons: HIV prevention in
incarcerated populations
Jordan Parsons and Chelsea Cox
Abstract
Purpose The purpose of this paper is to discuss the possibility of using pre-exposure prophylaxis
(PrEP) as an HIV harm reductionintervention in prisons. PrEP is primarilydiscussed in relation to men who
have sex with men (MSM),meaning other high-risk populations, such asprisoners, are often side-lined.
The authorswanted to consider how it could prove beneficialbeyond the MSM community.
Design/methodology/approach First, the authorsdiscuss whether the common objections to existing
HIV harm reduction interventions in prisons, such as needle exchanges, are applicable to PrEP. The
authors then applycommon objections to the provision of PrEP in the general populationto the provision
of PrEP in a prison context in orderto assess their strength. Finally, the authors discusswhat the authors
anticipateto be a key objection to PrEP in prisons: post-incarcerationaccess.
Findings The authors argue that bothsets of common objections considered are easily refuted in the
case of PrEP in prisons. The unique setting and nature of the intervention are such that it is without
immediately apparent flaws. In addressing post-incarceration access, the authors suggest that a
longitudinalconsideration of a prisoner’s HIV risk underminesthe objection.
Originality/value This discussion is of importance due to the significantly heightened risk of HIV
infection prisonersare subject to. Not only do effective HIV preventioninterventions in prisons contribute
to fair access to health for incarcerated individuals, but also to the widerfight against HIV. The authors
demonstratethat PrEP has potential as a new approachand call for further research in this area.
Keywords HIV, Offender health, Medical ethics, Injecting drug use, Harm reduction,Needle exchange
Paper type Conceptual paper
Introduction
Emtricitabine/tenofovir, a form of pre-exposure prophylaxis (PrEP), can significantly reduce
the risk of HIV infection in individuals who are at high risk. However, it is discussed
predominantly in relation to the risk of HIV infection from sexual contact within the men who
have sex with men (MSM) community, even though other high-risk population groups would
benefit from access.
One such population is incarcerated persons. Reports show incarcerated individuals to be
substantially more likely to be infected with HIV than the general public (Baker, 2018). This
is in large part due to an overrepresentation of substance dependency in prisoners
alongside a lack of accessible treatment and harm reduction programmes. The global
prison population has grown by 20 per cent in the last decade, outpacing population
growth, with a substantial proportion of this population serving time for drug-related
offences (Harm Reduction International, 2018). The need for effective and acceptable
interventions targeted at thosewith a drug dependency is evident.
The World Health Organization (WHO) recommends PrEP for population groups at
substantial risk of HIV infection (World Health Organization, 2016), and prisoners
undoubtedly fulfil this criterion. Information that delineates whichcohorts would benefit from
PrEP consistently includes intravenous drug users. In 2017, the WHO highlighted the
Jordan Parsons is based at
the Bristol Medical School,
University of Bristol, Bristol,
UK. Chelsea Cox is based
at the Faculty of Law,
University of Ottawa,
Ottawa, Canada.
Received 20 September 2019
Revised 10 October 2019
Accepted 25 October 2019
DOI 10.1108/IJPH-09-2019-0053 VOL. 16 NO. 2 2020, pp. 199-206, ©Emerald Publishing Limited, ISSN 1744-9200 jINTERNATIONAL JOURNAL OF PRISONER HEALTH jPAGE 199

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT